The cost of PrEP may be going down. The Food and Drug Administration has approved a generic version of Truvada, the only drug OK’d so far for use as pre-exposure prophylaxis, aimed at preventing ...

A long-awaited generic version of Truvada, used for both HIV treatment and PrEP, went on the market Friday, October 2. But the wholesale cost of the new pill from Teva Pharmaceuticals – about $1,455 – ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The HIV medication Truvada will come off ...

Bracing for generics to big-selling HIV prevention drug Truvada, Gilead Sciences is working to switch patients to its new option, Descovy. But the new med's additional benefits aren't worth the huge ...

A generic version of Truvada, the only drug approved to prevent HIV infection, will be available in September 2020, NBC News reports. Developed by Gilead Pharmaceuticals, Truvada is used for HIV ...

Pharmaceutical giant Gilead has agreed to release its exclusive patent to manufacture and sell the HIV-prevention drug Truvada. This means we could see a generic version of the pre-exposure ...

A U.K. court ruled against a patent extension filed by Gilead Sciences, the manufacturer of the highly effective HIV prevention drug Truvada, which will open the U.K. market to a generic version of ...

Gilead Sciences, makers of HIV prevention drug Truvada, have announced that a generic version will be available as early as September 2020. Truvada, also called PrEP, is a daily pill that prevents ...

When its U.S. patent cliff for HIV med Truvada was still on the horizon, Gilead Sciences won approval for follow-up med Descovy and launched an aggressive campaign to switch patients to the new drug.

Gilead Sciences quietly announced Wednesday that a generic version of its HIV drug Truvada would be available one year ahead of schedule, in September 2020. The news came after months of pressure from ...

Most doctors agree Truvada is a boon in AIDS prevention; others express concern. July 16, 2012— -- The Food and Drug Adminstration today announced the approval of the first drug for use in people ...